Notably, in PD patients, mutations in PINK1 prevent the phosphorylation of Miro at the Ser156 site, leading to the obstruction of Parkin-dependent ubiquitin degradation (Shlevkov et al., 2016; Narendra et al., 2012). The gene discussed is PRKN; the disease is Parkinson disease.